The authors demonstrated that the ligand, CXCL12, stimulated the CXCR4-expressing TNBC cell line, MDAMB-231, and led to an increase in the chemotaxis and chemoinvasion of tumor cells toward its ligand. Here, CXCL12 is linked to neoplasm.